 | • レポートコード：GIR-107A11774 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：産業機械＆装置 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、胃がん検査・治療・予防のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。胃がん検査・治療・予防の種類別市場規模（検査、治療、予防）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・胃がん検査・治療・予防の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Biogen Idec、Bristol Myers Squibb、Eli Lilly And Company、Glaxosmithkline Genentech, Inc、Hoffmann-La Roche Inc.、Immunogen Merck & Company、Novartis、Pacific Edge Diagnostics Nz、Pfizer、Roche/Genentech Oncolytics、Zova Biotherapeutics Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：検査、治療、予防 ・用途別分析2016年-2026年：病院、クリニック、その他 ・胃がん検査・治療・予防の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・胃がん検査・治療・予防のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・胃がん検査・治療・予防のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・胃がん検査・治療・予防の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・胃がん検査・治療・予防の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gastric Cancer Testing, Treatment and Prevention market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gastric Cancer Testing, Treatment and Prevention size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gastric Cancer Testing, Treatment and Prevention market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gastric Cancer Testing, Treatment and Prevention market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Test
Treatment
Prevention
Market segment by Application, can be divided into
Hospitals
Clinics
Other
Market segment by players, this report covers
Biogen Idec
Bristol Myers Squibb
Eli Lilly And Company
Glaxosmithkline Genentech, Inc
Hoffmann-La Roche Inc.
Immunogen Merck & Company
Novartis
Pacific Edge Diagnostics Nz
Pfizer
Roche/Genentech Oncolytics
Zova Biotherapeutics Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Gastric Cancer Testing, Treatment and Prevention
1.2 Classification of Gastric Cancer Testing, Treatment and Prevention by Type
1.2.1 Overview: Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type in 2020
1.2.3 Test
1.2.4 Treatment
1.2.5 Prevention
1.3 Global Gastric Cancer Testing, Treatment and Prevention Market by Application
1.3.1 Overview: Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Gastric Cancer Testing, Treatment and Prevention Market Size & Forecast
1.5 Global Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast by Region
1.5.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region, (2016-2021)
1.5.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.4 Europe Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.6 South America Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastric Cancer Testing, Treatment and Prevention Market Drivers
1.6.2 Gastric Cancer Testing, Treatment and Prevention Market Restraints
1.6.3 Gastric Cancer Testing, Treatment and Prevention Trends Analysis
2 Company Profiles
2.1 Biogen Idec
2.1.1 Biogen Idec Details
2.1.2 Biogen Idec Major Business
2.1.3 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.1.4 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Biogen Idec Recent Developments and Future Plans
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business
2.2.3 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.2.4 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bristol Myers Squibb Recent Developments and Future Plans
2.3 Eli Lilly And Company
2.3.1 Eli Lilly And Company Details
2.3.2 Eli Lilly And Company Major Business
2.3.3 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.3.4 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly And Company Recent Developments and Future Plans
2.4 Glaxosmithkline Genentech, Inc
2.4.1 Glaxosmithkline Genentech, Inc Details
2.4.2 Glaxosmithkline Genentech, Inc Major Business
2.4.3 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.4.4 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Glaxosmithkline Genentech, Inc Recent Developments and Future Plans
2.5 Hoffmann-La Roche Inc.
2.5.1 Hoffmann-La Roche Inc. Details
2.5.2 Hoffmann-La Roche Inc. Major Business
2.5.3 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.5.4 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Hoffmann-La Roche Inc. Recent Developments and Future Plans
2.6 Immunogen Merck & Company
2.6.1 Immunogen Merck & Company Details
2.6.2 Immunogen Merck & Company Major Business
2.6.3 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.6.4 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Immunogen Merck & Company Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.7.4 Novartis Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Pacific Edge Diagnostics Nz
2.8.1 Pacific Edge Diagnostics Nz Details
2.8.2 Pacific Edge Diagnostics Nz Major Business
2.8.3 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.8.4 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Pacific Edge Diagnostics Nz Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.9.4 Pfizer Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Roche/Genentech Oncolytics
2.10.1 Roche/Genentech Oncolytics Details
2.10.2 Roche/Genentech Oncolytics Major Business
2.10.3 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.10.4 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Roche/Genentech Oncolytics Recent Developments and Future Plans
2.11 Zova Biotherapeutics Inc.
2.11.1 Zova Biotherapeutics Inc. Details
2.11.2 Zova Biotherapeutics Inc. Major Business
2.11.3 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.11.4 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zova Biotherapeutics Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.2.2 Top 10 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.2.3 Market Competition Trend
3.3 Gastric Cancer Testing, Treatment and Prevention Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Market Share by Type (2016-2021)
4.2 Global Gastric Cancer Testing, Treatment and Prevention Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application (2016-2021)
5.2 Gastric Cancer Testing, Treatment and Prevention Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
6.2 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
6.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Country
6.3.1 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
6.3.2 United States Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
6.3.3 Canada Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
6.3.4 Mexico Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
7.2 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
7.3 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Country
7.3.1 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
7.3.2 Germany Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.3 France Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.5 Russia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.6 Italy Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
8.2 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
8.3 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Region
8.3.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Region (2016-2026)
8.3.2 China Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.3 Japan Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.4 South Korea Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.5 India Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.7 Australia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
9.2 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
9.3 South America Gastric Cancer Testing, Treatment and Prevention Market Size by Country
9.3.1 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
9.3.2 Brazil Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
9.3.3 Argentina Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
10.2 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
10.3 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Country
10.3.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
10.3.2 Turkey Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10.3.4 UAE Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Gastric Cancer Testing, Treatment and Prevention Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gastric Cancer Testing, Treatment and Prevention Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Region (2021-2026)
Table 6. Biogen Idec Corporate Information, Head Office, and Major Competitors
Table 7. Biogen Idec Major Business
Table 8. Biogen Idec Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 9. Biogen Idec Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 11. Bristol Myers Squibb Major Business
Table 12. Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 13. Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eli Lilly And Company Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly And Company Major Business
Table 16. Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 17. Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Glaxosmithkline Genentech, Inc Corporate Information, Head Office, and Major Competitors
Table 19. Glaxosmithkline Genentech, Inc Major Business
Table 20. Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 21. Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Hoffmann-La Roche Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Hoffmann-La Roche Inc. Major Business
Table 24. Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 25. Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Immunogen Merck & Company Corporate Information, Head Office, and Major Competitors
Table 27. Immunogen Merck & Company Major Business
Table 28. Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 29. Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 33. Novartis Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Pacific Edge Diagnostics Nz Corporate Information, Head Office, and Major Competitors
Table 35. Pacific Edge Diagnostics Nz Major Business
Table 36. Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 37. Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 41. Pfizer Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Roche/Genentech Oncolytics Corporate Information, Head Office, and Major Competitors
Table 43. Roche/Genentech Oncolytics Major Business
Table 44. Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 45. Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Zova Biotherapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Zova Biotherapeutics Inc. Major Business
Table 48. Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 49. Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) by Players (2019-2021)
Table 51. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Players (2019-2021)
Table 52. Breakdown of Gastric Cancer Testing, Treatment and Prevention by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Gastric Cancer Testing, Treatment and Prevention Players Head Office, Products and Services Provided
Table 54. Gastric Cancer Testing, Treatment and Prevention Mergers & Acquisitions in the Past Five Years
Table 55. Gastric Cancer Testing, Treatment and Prevention New Entrants and Expansion Plans
Table 56. Global Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) by Type (2016-2021)
Table 57. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Type (2016-2021)
Table 58. Global Gastric Cancer Testing, Treatment and Prevention Revenue Forecast by Type (2021-2026)
Table 59. Global Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2021)
Table 60. Global Gastric Cancer Testing, Treatment and Prevention Revenue Forecast by Application (2021-2026)
Table 61. North America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gastric Cancer Testing, Treatment and Prevention Picture
Figure 2. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type in 2020
Figure 3. Test
Figure 4. Treatment
Figure 5. Prevention
Figure 6. Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Gastric Cancer Testing, Treatment and Prevention Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Gastric Cancer Testing, Treatment and Prevention Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Region (2016-2026)
Figure 13. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Region in 2020
Figure 14. North America Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Gastric Cancer Testing, Treatment and Prevention Market Drivers
Figure 20. Gastric Cancer Testing, Treatment and Prevention Market Restraints
Figure 21. Gastric Cancer Testing, Treatment and Prevention Market Trends
Figure 22. Biogen Idec Recent Developments and Future Plans
Figure 23. Bristol Myers Squibb Recent Developments and Future Plans
Figure 24. Eli Lilly And Company Recent Developments and Future Plans
Figure 25. Glaxosmithkline Genentech, Inc Recent Developments and Future Plans
Figure 26. Hoffmann-La Roche Inc. Recent Developments and Future Plans
Figure 27. Immunogen Merck & Company Recent Developments and Future Plans
Figure 28. Novartis Recent Developments and Future Plans
Figure 29. Pacific Edge Diagnostics Nz Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Roche/Genentech Oncolytics Recent Developments and Future Plans
Figure 32. Zova Biotherapeutics Inc. Recent Developments and Future Plans
Figure 33. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Players in 2020
Figure 34. Gastric Cancer Testing, Treatment and Prevention Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Gastric Cancer Testing, Treatment and Prevention Revenue Market Share in 2020
Figure 36. Global Top 10 Players Gastric Cancer Testing, Treatment and Prevention Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Type in 2020
Figure 39. Global Gastric Cancer Testing, Treatment and Prevention Market Share Forecast by Type (2021-2026)
Figure 40. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Application in 2020
Figure 41. Global Gastric Cancer Testing, Treatment and Prevention Market Share Forecast by Application (2021-2026)
Figure 42. North America Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Type (2016-2026)
Figure 43. North America Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Application (2016-2026)
Figure 44. North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Country (2016-2026)
Figure 45. United States Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Type (2016-2026)
Figure 49. Europe Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Application (2016-2026)
Figure 50. Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Country (2016-2026)
Figure 51. Germany Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Region (2016-2026)
Figure 59. China Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Type (2016-2026)
Figure 66. South America Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Application (2016-2026)
Figure 67. South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の胃がんの検査・治療・予防市場予測（～2024年）：企業別、地域別、種類・用途別 Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years. There may be no symptoms of stomach cancer early on. Later, symptoms include feeling bloated after eating…- 世界の前立腺がん治療市場 2021：企業別、地域別、種類・用途別 The Prostate Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界の上皮性卵巣がん治療市場 2021：企業別、地域別、種類・用途別 The Epithelial Ovarian Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の男性乳がん治療市場 2021：企業別、地域別、種類・用途別 The Male Breast Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の肺がん治療薬市場 2021：企業別、地域別、種類・用途別 The Lung Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…